Home
/
Online library
/
Scientific papers / Cervical cancer
Peer-reviewed journal articles:
Book chapters:
Letters:
Books:
Electronic publications:
Publications / Cervical cancer
Topics:
Peer-reviewed journal articles:
 Hu S.Y., Zhao X.L., Zhao F.H., Wei L.H., Zhou Q., Niyazi M., Liu J.H., Wang C.Y., Li L.Y., Cheng X.D., Duan X.Z., Sauvaget C., Qiao Y.L., Sankaranarayanan R. Implementation of visual inspection with acetic acid and Lugol's iodine for cervical cancer screening in rural China. Int J Gynaecol Obstet. 2023 Feb;160(2):571-578. doi: 10.1002/ijgo.14368. |
| Joshi S., Anantharaman D., Muwonge R., Bhatla N., Panicker G., Butt J., Rani Reddy Poli U., Malvi S.G., Esmy P.O., Lucas E., Verma Y., Shah A., Zomawia E., Pimple S., Jayant K., Hingmire S., Chiwate A., Divate U., Vashist S., Mishra G., Jadhav R., Siddiqi M., Sankaran S., Pillai Rameshwari Ammal Kannan T., Kartha P., Shastri S.S., Sauvaget C., Radhakrishna Pillai M., Waterboer T., Muller M., Sehr P., Unger E.R., Sankaranarayanan R., Basu P. Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination. Vaccine. 2023 Jan 4;41(1):236-245. |
| Singh D., Vignat J., Lorenzoni V., Eslahi M., Ginsburg O., Lauby-Secretan B., Arbyn M., Basu P., Bray F., Vaccarella S. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023 Feb;11(2):e197-e206. |
| Asangbeh-Kerman S.L., Davidovic M., Taghavi K., Kachingwe J., Rammipi K.M., Muzingwani L., Pascoe M., Jousse M., Mulongo M., Mwanahamuntu M., Tapela N., Akintade O., Basu P., Dlamini X., Bohlius J. Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies. BMC Public Health. 2022 Aug 10;22(1):1530. |
| Baisley K., Kemp T.J., Kreimer A.R., Basu P., Changalucha J., Hildesheim A., Porras C., Whitworth H., Herrero R., Lacey C.J., Schiller J.T., Lucas E., Mutani P., Dillner J., Indangasi J., Muwonge R., Hayes R.J., Pinto L.A., Watson-Jones D. Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial. Lancet Glob Health. 2022 Oct;10(10):e1485-e1493. |
| Banerjee D., Mittal S., Mandal R., Basu P. Screening technologies for cervical cancer: Overview. Cytojournal. 2022 Mar 29;19:23. doi: 10.25259/CMAS_03_04_2021. |
| Basu P., Muwonge R. Alternative analysis of the data from a HPV vaccine study in India - Authors' reply. Lancet Oncol. 2022 Jan;23(1):e10. |
| Benider A., Bendahhou K., Sauvaget C., Mrabti H., Selmouni F., Muwonge R., Alaoui L., Lucas E., Chami Y., Abousselham L., Bennani M., Errihani H., Sankaranarayanan R., Bekkali R., Basu P. Evolution of patterns of care for women with cervical cancer in Morocco over a decade. BMC Cancer. 2022 May 2;22(1):479. |
| Broutet N., Jeronimo J., Kumar S., Almonte M., Murillo R., Huy N.V.Q., Denny L., Kapambwe S., Bhatla N., Sebitloane M., Zhao F., Gravitt P., Adsul P., Rangaraj A., Dalal S., Newman M., Chowdhury R., Church K., Nakisige C., Diop M., Parham G., Thomson K.A., Basu P., Steyn P. Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer. Prev Med. 2021 Dec 8;106906. |
| Fokom Domgue J., Pande M., Yu R., Manjuh F., Welty E., Welty T., Elit L., Lopez-Varon M., Rodriguez J., Baker E., Dangou J.M., Basu P., Plante M., Lecuru F., Randall T., Starr E., Kamgno J., Foxhall L., Waxman A., Hawk E., Schmeler K., Shete S. Development, Implementation, and Evaluation of a Distance Learning and Telementoring Program for Cervical Cancer Prevention in Cameroon. JAMA Netw Open. 2022 Nov 1;5(11):e2240801. |
| Hariprasad R., Mittal S., Basu P. Role of colposcopy in the management of women with abnormal cytology. Cytojournal. 2022 Jun 14;19:40. |
| Joshi S., Muwonge R., Kulkarni V., Mandolkar M., Lucas E., Pujari S., Sankaranarayanan R., Basu P. Can we increase the cervical cancer screening interval with an HPV test for women living with HIV? Results of a cohort study from Maharashtra, India. Int J Cancer. 2022 Jul 19. |
| Man I., Georges D., de Carvalho T.M., Ray Saraswati L., Bhandari P., Kataria I., Siddiqui M., Muwonge R., Lucas E., Berkhof J., Sankaranarayanan R., Bogaards J.A., Basu P., Baussano I. Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study. Lancet Oncol. 2022 Nov;23(11):1419-1429. |
| Prudden H.J., Achilles S.L., Schocken C., Broutet N., Canfell K., Akaba H., Basu P., Bhatla N., Chirenje Z.M., Delany-Moretlwe S., Denny L., Gamage D.G., Herrero R., Hutubessy R., Villa L.L., Murillo R., Schiller J.T., Stanley M., Temmerman M., Zhao F., Ogilvie G., Kaslow D.C., Dull P., Gottlieb S.L.; Therapeutic HPV Vaccine PPC Expert Consultation Group*. Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022. Vaccine. 2022 Sep 29;40(41):5843-5855. |
| Rol M.L., Picconi M.A., Ferrera A., Sanchez G.I., Hernandez M.L., Lineros J., Peraza A., Brizuela M., Mendoza L., Mongelos P., Cabrera Y., Rodriguez de la Pena M., Correa R.M., Teran C., Colque Reynaga D., Garcia L., Ramirez A.T., Hernandez-Nevarez P., Doimi F., Ramon M., Arias-Stella J., Zuniga M., Villagra V., Bobadilla M.L., Cardinal L., Valls J., Lucas E., Baena A., Fleider L., Venegas G., Cruz-Valdez A., Rodriguez G., Calderon A., Wiesner C., Luciani S., Broutet N., Herrero R., Almonte M. Implementing HPV testing in 9 Latin American countries: The laboratory perspective as observed in the ESTAMPA study. Front Med (Lausanne). 2022 Nov 17;9:1006038. |
| Sauvaget C., Bazikamwe S., Lucas E., Ndayikengurukiye A., Harerimana S., Barango P. Evaluation of effectiveness, acceptability and safety of thermal ablation in the treatment of cervical neoplasia in Burundi. Int J Cancer. 2022 Oct 1;151(7):1120-1126. |
| Sauvaget C., Bazikamwe S., Lucas E., Ndayikengurukiye A., Harerimana S., Barango P. Evaluation of effectiveness, acceptability, and safety of thermal ablation in the treatment of cervical neoplasia in Burundi. Int J Cancer. 2022 May 14. |
| Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Guideline Update. Shastri S.S., Temin S., Almonte M., Basu P., Campos N.G., Gravitt P.E., Gupta V., Lombe D.C., Murillo R., Nakisige C., Ogilvie G., Pinder L.F., Poli U.R., Qiao Y., Woo Y.L., Jeronimo J. JCO Glob Oncol. 2022 Sep;8:e2200217. |
| Selmouni F., Guy M., Muwonge R., Nassiri A., Lucas E., Basu P., Sauvaget C. Effectiveness of artificial intelligence-assisted decision-making to improve vulnerable women's participation in cervical cancer screening in France: a cluster randomized controlled trial (AppDate-You). JMIR Res Protoc. 2022 Jun 3 |
| Selmouni F., Sauvaget C., Dangbemey D.P., Kpebo D.D.O., Dieng N.M., Lucas E., Chami Khazraji Y., Bennani M., Bekkali R., Basu P. Lessons Learnt From Pilot Cervical Cancer Screening and Treatment Programmes Integrated to Routine Primary Health Care Services in Benin, Cote d'Ivoire, and Senegal. JCO Glob Oncol. 2022 Sep;8:e2200051. |
| Zhang L., Carvalho A.L., Mosquera I., Wen T., Lucas E., Sauvaget C., Muwonge R., Arbyn M., Weiderpass E., Basu P. An international consensus on the essential and desirable criteria for an 'organized' cancer screening programme. BMC Med. 2022 Mar 23;20(1):101. |
| Zhang L., Sauvaget C., Mosquera I., Basu P. Efficacy, acceptability and safety of ablative versus excisional procedure in the treatment of histologically confirmed CIN2/3: A systematic review. BJOG. 2022 Jun 11. |
| Zhang L., Zhao X., Hu S., Chen S., Zhao S., Dong L., Carvalho A.L., Muwonge R., Zhao F., Basu P. Triage performance and predictive value of the human gene methylation panel among women positive on self-collected HPV test: results from a prospective cohort study. Int J Cancer. 2022 Apr 22. doi: 10.1002/ijc.34041. |
| Zhang L., Zhao X., Hu S., Chen S., Zhao S., Dong L., Carvalho A.L., Muwonge R., Zhao F., Basu P. Triage performance and predictive value of the human gene methylation panel among women positive on self-collected HPV test: Results from a prospective cohort study. Int J Cancer. 2022 Sep 15;151(6):878-887. |
| Basu P., Alhomoud S., Taghavi K., Carvalho A.L., Lucas E., Baussano I. Cancer Screening in the Coronavirus Pandemic Era: Adjusting to a New Situation. JCO Glob Oncol. 2021 Mar;7:416-424. |
| Basu P., Lucas E., Zhang L., Muwonge R., Murillo R., Nessa A. Leveraging vertical COVID-19 investments to improve monitoring of cancer screening programme - A case study from Bangladesh. Prev Med. 2021 May 20:106624. |
| Basu P., Malvi S.G., Joshi S., Bhatla N., Muwonge R., Lucas E., Verma Y., Esmy P., Poli U.R.R., Shah A., Zomawia E., Pimple S., Jayant K., Hingmire S., Chiwate A., Divate U., Vashist S., Mishra G., Jadhav R., Siddiqi M., Sankaran S., Prabhu P.R., Kannan T.P.R.A., Varghese R., Shastri S.S., Anantharaman D., Gheit T., Tommasino M., Sauvaget C., Pillai M.R., Sankaranarayanan R. Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study. Lancet Oncol, Published online 8 October 2021. |
| Bhatla N., Aoki D., Sharma D.N., Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1:28-44. |
| Bouvard V., Wentzensen N., Mackie A., Berkhof J., Brotherton J., Giorgi-Rossi P., Kupets R., Smith R., Arrossi S., Bendahhou K., Canfell K., Chirenje Z.M., Chung M.H., Del Pino M., de Sanjose S., Elfstrom M., Franco E.L., Hamashima C., Hamers F.F., Herrington C.S., Murillo R., Sangrajrang S., Sankaranarayanan R., Saraiya M., Schiffman M., Zhao F., Arbyn M., Prendiville W., Indave Ruiz B.I., Mosquera-Metcalfe I., Lauby-Secretan B. The IARC Perspective on Cervical Cancer Screening. N Engl J Med. 2021 Nov 11;385(20):1908-1918. |
| Broutet N., Jeronimo J., Kumar S., Almonte M., Murillo R., Huy N.V.Q., Denny L., Kapambwe S., Bhatla N., Sebitloane M., Zhao F., Gravitt P., Adsul P., Rangaraj A., Dalal S., Newman M., Chowdhury R., Church K., Nakisige C., Diop M., Parham G., Thomson K.A., Basu P., Steyn P. Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer. Prev Med. 2021 Dec 8;106906. |
| Chargari C., Arbyn M., Learyd A., Abu-Rustum N.R., Basu P., Bray F., Chopra S., Nout R., Tanderup K., Viswanathan A.N., Zacharopouloum C., Soria J.C., Deutsch E., Gouy S., Morice P. Increasing global accessibility to high-level treatments for cervical cancers. Gynecologic Oncology. |
| Fadhil I., Alkhalawi E., Nasr R., Fouad H., Basu P., Camacho R., Pharma H.A. National cancer control plans across the Eastern Mediterranean region: challenges and opportunities to scale-up. Lancet Oncol 2021; 22: e517–29 |
| Joshi S., Muwonge R., Kulkarni V., Lucas E., Kulkarni S., Kand S., Mandolkar M., Baig M., Wankhede S., Surwase K., Pardeshi D., Basu P., Rengaswamy S. Mobile Screening Unit (MSU) for the Implementation of the 'Screen and Treat' Programme for Cervical Cancer Prevention In Pune, India. Asian Pac J Cancer Prev. 2021 Feb 1;22(2):413-418. |
| Mariz F.C., Bender N., Anantharaman D., Basu P., Bhatla N., Pillai M.R., Prabhu P.R., Sankaranarayanan R., Eriksson T., Pawlita M., Prager K., Sehr P., Waterboer T., Muller M., Lehtinen M. Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines. NPJ Vaccines. 2020 Feb 14;5(1):14. |
| Mwanahamuntu M., Kapambwe S., Pinder L.F., Matambo J., Chirwa S., Chisele S., Basu P., Prendiville W., Sankaranarayanan R., Parham G.P. The use of thermal ablation in diverse cervical cancer 'screen-and-treat' service platforms in Zambia. Int J Gynaecol Obstet. 2021 Jul 1. |
| Ringborg U., Berns A., Celis J.E., Heitor M., Tabernero J., Schuz J., Baumann M., Henrique R., Aapro M., Basu P., Beets-Tan R., Besse B., Cardoso F., Carneiro F., van den Eede G., Eggermont A., Frohling S., Galbraith S., Garralda E., Hanahan D., Hofmarcher T., Jonsson B., Kallioniemi O., Kasler M., Kondorosi E., Korbel J., Lacombe D., Carlos Machado J., Martin-Moreno J.M., Meunier F., Nagy P., Nuciforo P., Oberst S., Oliveiera J., Papatriantafyllou M., Ricciardi W., Roediger A., Ryll B., Schilsky R., Scocca G., Seruca R., Soares M., Steindorf K., Valentini V., Voest E., Weiderpass E., Wilking N., Wren A., Zitvogel L. The Porto European Cancer Research Summit 2021. Mol Oncol. 2021 Sep 13. doi: 10.1002/1878-0261.13078. |
| Ritchie D., Arbyn M., Basu P., Corbex M., Fidarova E., Ivanuš U., Papi G., Torode J., Zacharopoulou C. Europe's Path to Eliminating Cervical Cancer as a Public Health Problem. Lancet Reg Health Eur. 2022;12:100276. |
| Subramanian S., Jose R., Lal A., Augustine P., Jones M., Gopal B.K., Swayamvaran S.K., Saroji V., Samadarsi R., Sankaranarayanan R. Acceptability, utility, and cost of an mHealth cancer screening education application for training primary care physicians in India. Oncologist. 2021 Jul 19. |
| Villain P., Carvalho A.L., Lucas E., Mosquera I., Zhang L., Muwonge R., Selmouni F., Sauvaget C., Basu P., IARC COVID-19 impact study group. Cross-sectional survey of the impact of the COVID-19 pandemic on cancer screening programmes in selected low- and middle-income countries: study from the IARC COVID-19 impact study group. Int J Cancer. 2021 Feb 3. |
| Wentzensen N., Chirenje Z.M., Prendiville W. Treatment approaches for women with positive cervical screening results in low-and middle-income countries. Prev Med. 2021 Mar;144:106439 |
| Xia C., Xu X., Zhao X., Hu S., Qiao Y., Zhang Y., Hutubessy R., Basu P., Broutet N., Jit M., Zhao F. Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study. BMC Med. 2021 Mar 3;19(1):62. |
| Yadav K., Ginsburg O., Basu P., Mehrotra R. Telemedicine and Cancer Care in Low- and Middle-Income Countries During the SARS-CoV-2 Pandemic. JCO Glob Oncol. 2021 Sep;7:1633-1638. |
| Zhao S., Huang L., Basu P., Domingo E.J., Supakarapongkul W., Ling W.Y., Ocviyanti D., Rezhake R., Qiao Y., Tay E.H., Zhao F. Cervical cancer burden, status of implementation and challenges of cervical cancer screening in Association of Southeast Asian Nations (ASEAN) countries. Cancer Letters 525 (2022) 22–32. |
| Almonte M., Murillo R., Sanchez G.I., Gonzalez P., Ferrera A., Picconi M.A., Wiesner C., Cruz-Valdez A., Lazcano-Ponce E., Jeronimo J., Ferreccio C., Kasamatsu E., Mendoza L., Rodriguez G., Calderon A., Venegas G., Villagra V., Tatti S., Fleider L., Teran C., Baena A., Hernandez M.L., Rol M.L., Lucas E., Barbier S., Ramirez A.T., Arrossi S., Rodriguez M.I., Gonzalez E., Celis M., Martinez S., Salgado Y., Ortega M., Beracochea A.V., Perez N., Rodriguez de la Pena M., Ramon M., Hernandez-Nevarez P., Arboleda-Naranjo M., Cabrera Y., Salgado B., Garcia L., Retana M.A., Colucci M.C., Arias-Stella J., Bellido-Fuentes Y., Bobadilla M.L., Olmedo G., Brito-Garcia I., Mendez-Herrera A., Cardina L., Flores B., Penaranda J., Martinez-Better J., Soilan A., Figueroa J., Caserta B., Sosa C., Moreno A., Mural J., Doimi F., Gimenez D., Rodriguez H., Lora O., Luciani S., Broutet N., Darragh T., Herrero R. Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol. BMJ Open 2020;10:e035796. |
| Arbyn M., Bruni L., Kelly D., Basu P., Poljak M., Gultekin M., Bergeron C., Ritchie D., Weiderpass E. Tackling cervical cancer in Europe amidst the COVID-19 pandemic. Lancet Public Health. 2020 Jul 13;S2468-2667(20)30122-5. |
| Arbyn M., Gultekin M., Morice P., Nieminen P., Cruickshank M., Poortmans P., Kelly D., Poljak M., Bergeron C., Ritchie D., Schmidt D., Kyrgiou M., Van den Bruel A., Bruni L., Basu P., Bray F., Weiderpass E. The European Response to the WHO Call to Eliminate Cervical Cancer as a Public Health Problem. Int J Cancer. 2020 Jul 7. |
| Armaroli P., Riggi E., Basu P., Anttila A., Ponti A., Carvalho A.L., Dillner J., Elfstrom M.K., Giordano L., Lonnberg S., Ronco G., Senore C., Soerjomataram I., Tomatis M., Vale D.B., Jarm K., Sankaranarayanan R., Segnan N. Performance Indicators in Breast Cancer Screening in the European Union: A Comparison Across Countries of Screen Positivity and Detection Rates. Int J Cancer. 2020 Mar 11. |
| Baena A., De Vuyst H., Mesher D., Kasubi M., Yuma S., Mwaiselage J., Zouiouich S., Mlay P., Kahesa C., Landoulsi S., Hernandez M.L., Lucas E., Herrero R., Almonte M., Broutet N. Reproducibility of a rapid human papillomavirus test at different levels of the healthcare system in Tanzania: the AISHA study. Cancer Epidemiol Biomarkers Prev. August 20 2020. |
| Banerjee D., Mandal R., Mandal A., Ghosh I., Mittal S., Muwonge R., Lucas E., Basu P. A Prospective Randomized Trial to Compare Safety, Acceptability and Efficacy of Thermal Ablation and Cryotherapy in a Screen and Treat Setting. Asian Pac J Cancer Prev. 2020 May 1;21(5):1391-1398. |
| Basu P. Healthcare Systems Need to be Organized to Fight two Pandemics Simultaneously. Asian Pacific Journal of Cancer Care, 5(S1), 1-3. |
| Bhatla N., Meena J., Gupta K., Pal B., Divakar H., Bhalerao S., Peedicayil A., Srivastava S., Basu P., Purandare C.N.; FOGSI Expert Group. Human papillomavirus vaccination: Good clinical practice recommendations from the Federation of Obstetric and Gynecological Societies of India. J Obstet Gynaecol Res. 2020 Jul 6. |
| Bhatla N., Nessa A., Oswal K., Vashist S., Sebastian P., Basu P. Program organization rather than choice of test determines success of cervical cancer screening: Case studies from Bangladesh and India. Int J Gynaecol Obstet. 2020 Nov 18. |
| Castle P.E., Pierz A.J., Adcock R., Aslam S., Basu P.S., Belinson J.L., Cuzick J., El-Zein M., Ferreccio C., Firnhaber C., Franco E.L., Gravitt P.E., Isidean S.D., Lin J., Mahmud S.M., Monsonego J., Muwonge R., Ratnam S., Mahboobeh Safaeian M., Schiffman M., Smith J.S., Swarts A., Wright T., Van De Wyngard V., Xi L.F. A pooled analysis to compare the clinical characteristics of human papillomavirus-positive and -negative cervical precancers. Cancer Prev Res (Phila). 2020 Jul 12:canprevres.0182.2020. |
| Escriva-Boulley G., Mandrik O., Preau M., Herrero R., Villain P. Cognitions and behaviours of general practitioners in France regarding HPV vaccination: A theory-based systematic review. Prev Med. 2020 Nov 7:106323. |
| Joshi S., Mane A., Muwonge R., Divate U., Padbidri V., Kulkarni V., Gangakhedkar R., Sankaranarayanan R. Prevalence and predictors of bacterial vaginosis in HIV-infected women in Maharashtra, India. Int J STD AIDS. 2020 Mar 31:956462419878333. |
| Kumar S., Khanduri A., Sidibe A., Morgan C., Torode J., Basu P., Bhatla N., Schocken C., Bloem P. Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low- and lower-middle-income countries. Int J Gynaecol Obstet. 2020 Nov 13. |
| Mandal R., Ghosh I., Banerjee D., Mittal S., Muwonge R., Roy C., Panda C., Vernekar M., Frappart L., Basu P. Correlation Between p16/Ki-67 Expression and the Grade of Cervical Intraepithelial Neoplasias. Int J Gynecol Pathol. 2020 Jul;39(4):384-390. |
| Mariz F.C., Bender N., Anantharaman D., Basu P., Bhatla N., Pillai M.R., Prabhu P.R., Sankaranarayanan R., Eriksson T., Pawlita M., Prager K., Sehr P., Waterboer T., Muller M., Lehtinen M. Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines. NPJ Vaccines. 2020 Feb 14;5:14. |
| Muwonge R., Basu P., Gheit T., Anantharaman D., Verma Y., Bhatla N., Joshi S., Esmy P.O., Poli U.R.R., Shah A., Zomawia E., Shastri S.S., Pimple S., Prabhu P.R., Hingmire S., Chiwate A., Sauvaget C., Lucas E., Malvi S.G., Siddiqi M., Sankaran S., Kannan T.P.R.A., Varghese R., Divate U., Vashist S., Mishra G., Jadhav R., Tommasino M., Pillai M.R., Sankaranarayanan R., Jayant K.; Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study. Indian HPV vaccine study group. PLoS One. 2020 Dec 29;15(12):e0244242. |
| Poli U.R., Muwonge R., Bhoopal T., Lucas E., Basu P. Feasibility, Acceptability, and Efficacy of a Community Health Worker-Driven Approach to Screen Hard-to-Reach Periurban Women Using Self-Sampled HPV Detection Test in India. JCO Glob Oncol. 2020 Apr;6:658-666. |
| Ponti A., Basu P., Ritchie D., Anttila A., Carvalho A.L., Senore C., Mallafre-Larrosa M., Piccinelli C., Ronco G., Soerjomataram I., Primic-Žakelj M., Dillner J., Elfstrom M.K., Lonnberg S., Vale D.B., Tomatis M., Armaroli P., Giordano L., Sankaranarayanan R., Segnan N. Key issues that need to be considered while revising the current Annex of the European Council Recommendation (2003) on cancer screening. Int J Cancer. 2020 Jan 22. |
| Shiko Y., Konno R., Konishi H., Sauvaget C., Ohashi Y., Kakizoe T. Effectiveness of HPV vaccination against the development of high-grade cervical lesions in young Japanese women. BMC Infect Dis. 2020 Nov 5;20(1):808. |
| Taghavi K., Moono M., Mwanahamuntu M., Basu P., Limacher A., Tembo T., Kapesa H., Hamusonde K., Asangbeh S., Sznitman R., Low N., Manasyan A., Bohlius J. Screening test accuracy to improve detection of precancerous lesions of the cervix in women living with HIV: a study protocol. BMJ Open 2020;10:e037955. |
| Taghavi K., Rohner E., Basu P., Low N., Rutjes A., Bohlius J. Screening test accuracy of portable devices that can be used to perform colposcopy for detecting CIN2+ in low- and middle-income countries: a systematic review and meta-analysis. BMC Womens Health. 2020 Nov 16;20(1):253. |
| Tsang S.H., Basu P., Bender N., Herrero R., Kemp T.J., Kreimer A.R., Muller M., Panicker G., Pawlita M., Pinto L.A., Sampson J.N., Sankaranarayanan R., Schussler J., Sehr P., Sierra M.S., Unger E.R., Waterboer T., Hildesheim A.; Costa Rica Vaccine Trial (CVT) Group. Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines. Vaccine. 2020 Jul 23:S0264-410X(20)30917-8. |
| Whitworth H.S., Gallagher K.E., Howard N., Mounier-Jack S., Mbwanji G., Kreimer A.R., Basu P., Kelly H., Drolet M., Brisson M., Watson-Jones D. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials. Vaccine. 2019 Dec 20. pii: S0264-410X(19)31659-7. |
| Zhao X.L., Liu Z.H., Zhao S., Hu S.Y., Muwonge R., Duan X.Z., Du L.J., Su C.F., Xiang X.E., Zhang X., Pan Q.J., Qiao Y.L., Sankaranarayanan R., Zhao F.H., Basu P. Efficacy of Point-of-care Thermal Ablation Among High-risk Human Papillomavirus Positive Women in China. Int J Cancer. 2020 Sep 7. |
| Zhao X.L., Xu X.Q., Duan X.Z., Rezhake R., Hu S.Y., Wang Y., Xia C.F., Zhang X., Qiao Y.L., Sankaranarayanan R., Zhao F.H., Basu P. Comparative performance evaluation of different HPV tests and triaging strategies using self-samples and feasibility assessment of thermal ablation in 'colposcopy and treat' approach: a population-based study in rural China. Int J Cancer. 2020 Jan 22. |
| Zhao Y., Zhao F., Hu S., Zhang X., Zhang W., Pan Q., Gage J.C., Sankaranarayanan R., Qiao Y. Value of multi-quadrants biopsy: Pooled analysis of 11 population-based cervical cancer screening studies. Chin J Cancer Res. 2020 Jun;32(3):383-394. |
| Basu P., Hutubessy R., Broutet N. Cervical cancer: WHO called for elimination, not eradication. BMJ. 2019 Sep 26;366:l5668. |
| Basu P., Mahajan M., Patira N., Prasad S., Mogri S., Muwonge R., Lucas E., Sankaranarayanan R., Iyer S., Naik N., Jain K. A pilot study to evaluate home-based screening for the common non-communicable diseases by a dedicated cadre of community health workers in a rural setting in India. BMC Public Health. 2019 Jan 3;19(1):14. |
| Bhatla N., Singhal S., Saraiya U., Srivastava S., Bhalerao S., Shamsunder S., Chavan N., Basu P., Purandare C.N. on behalf of FOGSI Expert group. Screening and management of preinvasive lesions of the cervix: Good clinical practice recommendations from the Federation of Obstetrics and Gynaecologic Societies of India (FOGSI). J Obstet Gynaecol Res. 2019 Dec 9. doi: 10.1111/jog.14168. |
| Mahajan M., Naik N., Jain K., Patira N., Prasad S., Mogri S., Muwonge R., Lucas E., Faruq F., Sankaranarayanan R., Iyer S., Basu P. Study of Knowledge, Attitudes, and Practices Toward Risk Factors and Early Detection of Noncommunicable Diseases Among Rural Women in India. J Glob Oncol. 2019 Apr;(5):1-10. |
| Ndizeye Z., Menon S., Van Geertruyden J.P., Sauvaget C., Jacquemyn Y., Bogers J.P., Benoy I., Vanden Broeck D. Performance of OncoE6TM Cervical Test in detecting cervical precancer lesions in HIV-positive women attending an HIV clinic in Bujumbura, Burundi: a cross-sectional study. BMJ Open. 2019 Sep 6;9(9):e029088. |
| Pinder L.F., Parham G.P., Basu P., Muwonge R., Lucas E., Nyambe N., Sauvaget C., Mwanahamuntu M.H., Sankaranarayanan R., Prendiville W. Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial. Lancet Oncol. 2019 Nov 13. pii: S1470-2045(19)30635-7. |
| Pourghazian N., Sankaranarayanan R., Alhomoud S., Slama S. Strengthening the early detection of common cancers in the Eastern Mediterranean Region. East Mediterr Health J. 2019 Nov 25;25(11):767-768. doi: 10.26719/2019.25.11.767. |
| Randall T.C., Sauvaget C., Muwonge R., Trimble E.L., Jeronimo J. Authors response to Papoutsis and colleagues letter to the editor regarding: Worthy of further consideration: An updated meta-analysis to address the feasibility, acceptability, safety and efficacy of thermal ablation in the treatment of cervical cancer precursor lesions. Prev Med. 2019 Feb 10. |
| Sangrajrang S., Laowahutanont P., Wongsena M., Muwonge R., Imsamran W., Ploysawang P., Basu P. Human papillomavirus (HPV) DNA and mRNA primary cervical cancer screening: Evaluation and triaging options for HPV-positive women. J Med Screen. 2019 Jul 31. |
| Sankaranarayanan R., Basu P., Kaur P., Bhaskar R., Singh G.B., Denzongpa P., Grover R.K., Sebastian P., Saikia T., Oswal K., Kanodia R., Dsouza A., Mehrotra R., Rath G.K., Jaggi V., Kashya S., Kataria I., Hariprasad R., Sasieni P., Bhatla N., Rajaraman P., Trimble E.L., Swaminathan S., Purushotham A. Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts. Lancet Oncol. 2019 Nov;20(11):e637-e644. |
| Selmouni F., Belakhel L., Sauvaget C., Abousselham L., Lucas E., Muwonge R., Sankaranarayanan R., Khazraji Y.C., Basu P. Evaluation of the national cervical cancer screening program in Morocco: achievements and challenges. J Med Screen. 2019 Jan 16:969141318824627. |
| Thulaseedharan J.V., Frie K.G., Sankaranarayanan R. Challenges of health promotion and education strategies to prevent cervical cancer in India: A systematic review. J Educ Health Promot. 2019 Nov 29;8:216. |
| Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow up cohort study. Basu P., Muwonge R., Bhatla N., Nene B.M., Joshi S., Esmy P.O., Poli U.R.R., Joshi G., Verma Y., Zomawia E., Shastri S.S., Pimple S., Anantharaman D., Prabhu P.R., Hingmire S., Sauvaget C., Lucas E., Pawlita M., Gheit T., Jayant K., Malvi S.G., Siddiqi M., Michel A., Butt J., Sankaran S., Rameshwari Ammal Kannan T.P., Varghese R., Divate U., Willhauck-Fleckenstein M., Waterboer T., Muller M., Sehr P., Vashist S., Mishra G., Jadhav R., Thorat R., Tommasino M., Pillai M.R., Sankaranarayanan R.; Indian HPV vaccine study group. Papillomavirus Res. 2019 Jan 31. pii: S2405-8521(18)30133-2. |
| Vale D.B.,Sauvaget C., Murillo R., Muwonge R., Zeferino L.C., Sankaranarayanan R. Correlation of Cervical Cancer Mortality with Fertility, Access to Health Care and Socioeconomic Indicators. Rev Bras Ginecol Obstet. 2019 Mar 25. |
| Whitworth H.S., Gallagher K.E., Howard N., Mounier-Jack S., Mbwanji G., Kreimer A.R., Basu P., Kelly H., Drolet M., Brisson M., Watson-Jones D. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials. Vaccine. 2019 Dec 20. pii: S0264-410X(19)31659-7. |
| Basu P., Mehta A., Jain M., Gupta S., Nagarkar R.V., John S., Petit R. A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer. Int J Gynecol Cancer. 2018 May;28(4):764-772. |
| Basu P., Mittal S., Bhadra Vale D, Chami Kharaji Y. Secondary prevention of cervical cancer. Best Pract Res Clin Obstet Gynaecol. 2018 Feb;47:73-85. |
| Basu P., Mukhopadhyay A., Konishi I. Targeted therapy for gynecologic cancers: Toward the era of precision medicine. Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:131-136. |
| Basu P., Ponti A., Anttila A., Ronco G., Senore C., Vale D. B., Segnan N., Tomatis M., Soerjomataram I., Primic Zakelj M., Dillner J., Elfstrom K. M., Lonnberg S., Sankaranarayanan R. Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report. Int J Cancer; 2018; 142(1): 44-56. |
| Basu P., Ponti A., Anttila A., Ronco G., Senore C., Vale D.B., Segnan N., Tomatis M., Soerjomataram I., Primic Žakelj M., Dillner J., Elfstrom K.M., Lonnberg S., Sankaranarayanan R. Author's reply to: Cancer screening policy in Hungary. Int J Cancer. 2018 Aug 15;143(4):1005. |
| Basu P., Ponti A., Anttila A., Ronco G., Senore C., Vale D.B., Segnan N., Tomatis M., Soerjomataram I., Žakelj M.P., Dillner J., Elfstrom K.M., Lonnberg S., Sankaranarayanan R. Author's reply to: Implementation and organization of cancer screening in France. Int J Cancer. 2018 Jun 26. doi: 10.1002/ijc.31629. |
| Basu P., Taghavi K., Hu S.Y., Mogri S., Joshi S. Management of cervical premalignant lesions. Curr Probl Cancer. 2018 Mar - Apr;42(2):129-136. |
| Bhatla N., Aoki D., Sharma D.N., Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:22-36. |
| Bhatla N., Nene B.M., Joshi S., Esmy P.O., Poli U.R.R., Joshi G., Verma Y., Zomawia E., Pimple S., Prabhu P.R., Basu P., Muwonge R., Hingmire S., Sauvaget C., Lucas E., Pawlita M., Gheit T., Jayant K., Malvi S.G., Siddiqi M., Michel A., Butt J., Sankaran S., Kannan T.P.R.A., Varghese R., Divate U., Willhauck-Fleckenstein M., Waterboer T., Muller M., Sehr P., Kriplani A., Mishra G., Jadhav R., Thorat R., Tommasino M., Pillai M.R., Sankaranarayanan R.; Indian HPV vaccine study group. Are two doses of human papillomavirus vaccine sufficient for girls aged 15-18 years? Results from a cohort study in India. Papillomavirus Res. 2018 Jun;5:163-171. |
| Garland S.M., Giuliano A., Brotherton J., Moscicki A.B., Stanley M., Kaufmann A.M., Bhatla N., Sankaranarayanan R., Palefsky J.M., de Sanjose S.; IPVS. IPVS statement moving towards elimination of cervical cancer as a public health problem. Papillomavirus Res. 2018 Jun;5:87-88. |
| Joshi S., Muwonge R., Kulkarni V., Deodhar K., Mandolkar M., Lucas E., Sankaranarayanan R. Incidence of cervical intraepithelial neoplasia in women infected with human immunodeficiency virus (HIV) with no evidence of disease at baseline: results of a prospective cohort study with up to 6.4 years of follow-up from India. Int J Cancer. 2018 Aug 22. |
| Konno R., Konishi H., Sauvaget C., Ohashi Y., Kakizoe T. Effectiveness of HPV vaccination against high grade cervical lesions in Japan. Vaccine. 2018 Dec 18;36(52):7913-7915. |
| Lyons G., Sankaranarayanan R., Millar A.B., Slama S. Scaling up cancer care in the WHO Eastern Mediterranean Region. East Mediterr Health J. 2018 Apr 5;24(1):104-110. |
| Mandal R, Basu P. Cancer screening and early diagnosis in low and middle income countries: Current situation and future perspectives. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Oct 23. |
| Randall T.C., Sauvaget C., Muwonge R., Trimble E.L., Jeronimo J. Worthy of further consideration: An updated meta-analysis to address the feasibility, acceptability, safety and efficacy of thermal ablation in the treatment of cervical cancer precursor lesions. Prev Med. 2018 Oct 17;118:81-91. |
| Robles C., Wiesner C., Martinez S., Salgado Y., Hernandez M., Lucas E., Lineros J., Romero P., Herrero R., Almonte M., Murillo R. Impact of operational factors on HPV positivity rates in an HPV-based screening study in Colombia. Int J Gynaecol Obstet. 2018 Oct;143(1):44-51. |
| Sankaranarayanan R., Joshi S., Muwonge R., Esmy P.O., Basu P., Prabhu P., Bhatla N., Nene B.M., Shaw J., Poli U.R.R., Verma Y., Zomawia E., Pimple S., Tommasino M., Pawlita M., Gheit T., Waterboer T., Sehr P., Pillai M.R.; Indian HPV vaccine study group. Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study. Vaccine. 2018 Aug 6;36(32 Pt A):4783-4791. |
| Selmouni F., Zidouh A., Belakhel L., Sauvaget C., Bennani M., Khazraji Y.C., Benider A., Wild C.P., Bekkali R., Fadhil I., Sankaranarayanan R. Tackling cancer burden in low-income and middle-income countries: Morocco as an exemplar. Lancet Oncol. 2018 Feb;19(2):e93-e101. |
| Sivaram S., Majumdar G., Perin D., Nessa A., Broeders M., Lynge E., Saraiya M., Segnan N., Sankaranarayanan R., Rajaraman P., Trimble E., Taplin S., Rath G.K., Mehrotra R. Population-based cancer screening programmes in low-income and middle-income countries: regional consultation of the International Cancer Screening Network in India. Lancet Oncol. 2018 Feb;19(2):e113-e122. |
| Utada M., Chernyavskiy P. Lee W.J., Franceschi S., Sauvaget C., Berrington de Gonzalez A., Withrow D.R. Increasing risk of uterine cervical cancer among young Japanese women: Comparison of incidence trends in Japan, South Korea and Japanese-Americans between 1985 and 2012. Int J Cancer. 2018 Nov 25. |
| Vale D.B., Anttila A., Ponti A., Senore C., Sankaranaryanan R., Ronco G., Segnan N., Tomatis M., Žakelj M.P., Elfstrom K.M., Lonnberg S., Dillner J., Basu P. Invitation strategies and coverage in the population-based cancer screening programmes in the European Union. Eur J Cancer Prev. 2018 Mar 21. |
| Vale D.B., Sauvaget C., Muwonge R., Thuler L.C.S., Basu P., Zeferino L.C., Sankaranarayanan R. Level of human development is associated with cervical cancer stage at diagnosis. J Obstet Gynaecol. 2018 Sep 19:1-5. |
| Zhang L., Xu X.Q., Hu S.Y., Chen F., Zhang X., Pan Q.J., Zhang W.H., Feng R.M., Dong L., Zhang Q., Ma J.F., Sauvaget C., Zhao F.H., Qiao Y.L., Sankaranarayanan R. Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China. Gynecol Oncol. 2018 Nov;151(2):221-228. |
| Basu P., Meheus F., Chami Y., Hariprasad R., Zhao F., Sankaranarayanan R. Management algorithms for cervical cancer screening and precancer treatment for resource-limited settings. Int J Gynaecol Obstet; 2017; 26-32. |
| Basu P., Mittal S., Bhadra Vale D., Chami Kharaji Y. Secondary prevention of cervical cancer. Best Pract Res Clin Obstet Gynaecol. 2017 Sep 6. pii: S1521-6934(17)30130-X. |
| Basu P., Ponti A., Anttila A., Ronco G., Senore C., Vale D.B., Segnan N., Tomatis M., Soerjomataram I., Primic Žakelj M., Dillner J., Elfstrom K.M., Lonnberg S., Sankaranaryanan R. Status of implementation and organization of cancer screening in the European Union Member States - summary results from the second European screening report. Int J Cancer. 2018 Jan 1;142(1):44-56. |
| Basu P., Vale D. Screening for Epithelial Ovarian Cancer: An Updated Review. Indian Journal of Gynecologic Oncology. 2017;15(1). |
| Denny L., de Sanjose S., Mutebi M., Anderson B.O., Kim J., Jeronimo J., Herrero R., Yeates K., Ginsburg O., Sankaranarayanan R. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries. Lancet. 2017;389(10071):861-870. |
| Garland S. M., Brotherton J. M. L., Moscicki A. B., Kaufmann A. M., Stanley M., Bhatla N., Sankaranarayanan R., de Sanjose S., Palefsky J. M. HPV vaccination of immunocompromised hosts. Papillomavirus Res; 2017; 35-38. |
| Ghosh I., Muwonge R., Mittal S., Banerjee D., Kundu P., Mandal R., Biswas J., Basu P. Association between high risk human papillomavirus infection and co-infection with Candida spp. And Trichomonas vaginalis in women with cervical premalignant and malignant lesions. J Clin Virol. 2017;87:43-8. |
| Holme F., Kapambwe S., Nessa A., Basu P., Murillo R., Jeronimo J. Scaling up proven innovative cervical cancer screening strategies: Challenges and opportunities in implementation at the population level in low- and lower-middle-income countries. Int J Gynaecol Obstet; 2017; 63-68. |
| Jeronimo J., Castle P.E., Temin S., Denny L., Gupta V., Kim J.J., Luciani S., Murokora D., Ngoma T., Qiao Y., Quinn M., Sankaranarayanan R., Sasieni P., Schmeler K.M., Shastri S.S. Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline. J Glob Oncol. 2017 Oct; 3(5): 635–657. |
| Mittal S., Basu P., Muwonge R., Banerjee D., Ghosh I., Sengupta M.M., Das P., Dey P., Mandal R., Panda C., Biswas J., Sankaranarayanan R. Risk of high grade precancerous lesions and invasive cancers in high risk HPV positive women with normal cervix or CIN 1 at baseline - a population based cohort study. Int J Cancer. 2017;140(8):1850-1859. |
| Nessa A., Naud P., Esmy P.O., Joshi S., Rema P., Wesley R., Kamal M., Sauvaget C., Muwonge R., Sankaranarayanan R. Efficacy, safety, and acceptability of treating cervical intraepithelial neoplasia with thermal coagulation: A pooled analysis using data from Bangladesh, Brazil and India. J Clin Gynecol Obstet. 2017;6(3-4):58-64 |
| Roychowdhury A., Samadder S., Das P., Mandloi S., Addya S., Chakraborty C., Basu P. S., Mondal R., Roy A., Chakrabarti S., Roychoudhury S., Panda C. K. Integrative genomic and network analysis identified novel genes associated with the development of advanced cervical squamous cell carcinoma. Biochimica et biophysica acta. 2017;1861(1 Pt A):2899-911. |
| Roychowdhury A., Samadder S., Islam M.S., Chaudhury K., Roy A., Banerjee D., Mandal R., Basu P.S., Roychoudhury S., Panda C.K. Identification of Changes in the Human Papilloma Virus 16 (HPV16) Genome During Early Dissemination of Cervical Cancer Cells May Complement Histological Diagnosis of Lymph Node Metastasis. Pathol Oncol Res. 2017 Jan 19. |
| Sangrajrang S., Laowahutanont P., Wongsena M., Muwonge R., Karalak A., Imsamran W., Senkomago V., Sankaranarayanan R. Comparative accuracy of Pap smear and HPV screening in Ubon Ratchathani in Thailand. Papillomavirus Res; 2017; 30-35. |
| Zhang Q., Dong L., Hu S., Feng R., Zhang X., Pan Q., Ma J., Zhang L., Zhao X., Sankaranarayanan R., Qiao Y., Zhao F. Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in China. Int J Cancer; 2017; 141(6): 1110-1119. |
| Banerjee D., Ghosh I., Das P., Mandal R., Basu P.. Extra-Genital Bowen's Disease on Abdomen Co-existing with Vulvar Intraepithelial Neoplasia. J Obstet Gynaecol India. 2016;66(3):199-201. |
| Basu P., Banerjee D., Mittal S., Mandal R., Ghosh I., Das P., Muwonge R., Biswas J. Evaluation of a compact, rechargeable, magnifying device to triage VIA and HPV positive women in a cervical cancer screening program in rural India. Cancer Causes Control. 2016;27(10):1253-9. |
| Basu P., Bhatla N., Ngoma T., Sankaranarayanan R. Less than 3 doses of the HPV vaccine - Review of efficacy against virological and disease end points. Hum Vaccin Immunother. 2016;12(6):1394-402. |
| Basu P., Jenson A. B., Majhi T., Choudhury P., Mandal R., Banerjee D., Biswas J., Pan J., Rai S. N., Ghim S. J., Miller D. Phase 2 Randomized Controlled Trial of Radiation Therapy Plus Concurrent Interferon-Alpha and Retinoic Acid Versus Cisplatin for Stage III Cervical Carcinoma. Int J Radiat Oncol Biol Phys. 2016;94(1):102-10. |
| Basu P., Muwonge R., Mittal S., Banerjee D., Ghosh I., Panda C., Mandal R., Sankaranarayanan R. Implications of semi-quantitative HPV viral load estimation by Hybrid capture 2 in colposcopy practice. J Med Screen. 2016;23(2):104-10. |
| Ghosh I., Mittal S., Banerjee D., Chowdhury N., Basu P. Study of Correlation of Cervical Epithelial Thickness With the Grade of Colposcopic Abnormality. Int J Gynecol Pathol. 2016 May;35(3):269-74. |
| Jayant K., Sankaranarayanan R., Thorat R. V., Muwonge R., Hingmire S. J., Panse N. S., Shastri S. S., Malvi S. G., Nene B. Improved Survival of Cervical Cancer Patients in a Screened Population in Rural India. Asian Pac J Cancer Prev. 2016;17(11):4837-44. |
| Mittal S., Mandal R., Banerjee D., Das P., Ghosh I., Panda C., Biswas J., Basu P. HPV detection-based cervical cancer screening program in low-resource setting: lessons learnt from a community-based demonstration project in India. Cancer Causes Control. 2016;27(3):351-8. |
| Muwonge R., Ngo Mbus L., Ngoma T., Gombe Mbalawa C., Dolo A., da Ganda Manuel M., Nouhou H., Nacoulma M., Mwaiselage J., Koulibaly M., Bayo S., Nsonde Malanda J., De Vuyst H., Herrero R., Sankaranarayanan R., Keita N. Socio-demographic and reproductive determinants of cervical neoplasia in seven sub-Sahara African countries. Cancer Causes Control. 2016;27(12):1437-46. |
| Naud P. S., Muwonge R., Passos E. P., Magno V., Matos J., Sankaranarayanan R. Efficacy, safety, and acceptability of thermocoagulation for treatment of cervical intraepithelial neoplasia in a hospital setting in Brazil. Int J Gynaecol Obstet. 2016;133(3):351-4. |
| Sankaranarayanan R., Bhatla N., Basu P. Current global status & impact of human papillomavirus vaccination: Implications for India. Indian J Med Res. 2016;144(2):169-80. |
| Sankaranarayanan R., Prabhu P. R., Pawlita M., Gheit T., Bhatla N., Muwonge R., Nene B. M., Esmy P. O., Joshi S., Poli U. R., Jivarajani P., Verma Y., Zomawia E., Siddiqi M., Shastri S. S., Jayant K., Malvi S. G., Lucas E., Michel A., Butt J., Vijayamma J. M., Sankaran S., Kannan T. P., Varghese R., Divate U., Thomas S., Joshi G., Willhauck-Fleckenstein M., Waterboer T., Muller M., Sehr P., Hingmire S., Kriplani A., Mishra G., Pimple S., Jadhav R., Sauvaget C., Tommasino M., Pillai M. R. Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study. Lancet Oncol. 2016;17(1):67-77. |
| Santesso N., Mustafa R. A., Schunemann H. J., Arbyn M., Blumenthal P. D., Cain J., Chirenje M., Denny L., De Vuyst H., Eckert L. O., Forhan S. E., Franco E. L., Gage J. C., Garcia F., Herrero R., Jeronimo J., Lu E. R., Luciani S., Quek S. C., Sankaranarayanan R., Tsu V., Broutet N. (2016) World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer. Int J Gynaecol Obstet; 132(3):252-8. |
| Selmouni F., Sauvaget C., Belakhel L., Lucas E., Khouchoua M., Sankaranarayanan R. Organization and evaluation of a pilot cervical cancer screening program in Morocco. Int J Gynaecol Obstet. 2016;132(1):25-8. |
| Selmouni F., Sauvaget C., Zidouh A., Plaza C. A., Muwonge R., Rhazi K. E., Basu P., Sankaranarayanan R. Evaluation of Provider Skills in Performing Visual Inspection with Acetic Acid in the Cervical Cancer Screening Program in the Meknes-Tafilalet Region of Morocco. Asian Pac J Cancer Prev. 2016;17(9):4313-8. |
| Subramanian S., Sankaranarayanan R., Esmy P.O., Thulaseedharan J.V., Swaminathan R., Thomas S. Clinical trial to implementation: Cost and effectiveness considerations for scaling up cervical cancer screening in low- and middle-income countries. Journal of Cancer Policy. 2016;7:4-11. |
| Vale D. B., Sauvaget C., Muwonge R., Ferlay J., Zeferino L. C., Murillo R., Sankaranarayanan R. Disparities in time trends of cervical cancer mortality rates in Brazil. Cancer Causes Control. 2016;27(7):889-96. |
| Basu P., Mittal S., Banerjee D., Singh P., Panda C., Dutta S., Mandal R., Das P., Biswas J., Muwonge R., Sankaranarayanan R. Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a Cervical Cancer Screening Demonstration Project in India. Int J Cancer. 2015;137(4):859-67. |
| Camargo M., Russomano F., Tristao M., Huf G., Prendiville W. Large loop versus straight-wire excision of the transformation zone for treatment of cervical intraepithelial neoplasia: a randomised controlled trial of electrosurgical techniques. BJOG. 2015;122(4):552-7. |
| Denny L., Prendiville W. Cancer of the cervix: Early detection and cost-effective solutions. Int J Gynaecol Obstet. 2015;131 Suppl 1:S28-S32. |
| Joshi S., Kulkarni V., Gangakhedkar R., Sankaranarayanan R. Are we missing opportunities to prevent cervical cancer in HIV-infected women in India? Indian J Med Res. 2015;142(5):610-3. |
| Parham G.P., Mwanahamuntu M.H., Kapambwe S., Muwonge R., Bateman A.C., Blevins M., Chibwesha C.J., Pfaendler K.S., Mudenda V., Shibemba A.L., Chisele S., Mkumba G., Vwalika B., Hicks M.L., Vermund S.H., Chi B.H., Stringer J.S., Sankaranarayanan R., Sahasrabuddhe V.V. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. PLoS One. 2015;10(4):e0122169. |
| Prendiville W. Two-grade Bethesda system of reporting in cervical screening: colposcopist's view. Cytopathology. 2015;26(6):351-3. |
| Rajaraman P., Anderson B.O., Basu P., Belinson J.L., Cruz A.D., Dhillon P.K., Gupta P., Jawahar T.S., Joshi N., Kailash U., Kapambwe S., Katoch V.M., Krishnan S., Panda D., Sankaranarayanan R., Selvam J.M., Shah K.V., Shastri S., Shridhar K., Siddiqi M., Sivaram S., Seth T., Srivastav A., Trimble E., Mehrotra R. Recommendations for screening and early detection of common cancers in India. Lancet Oncol. 2015;16(7):e352-61. |
| Sankaranarayanan R., Qiao Y.L., Keita N. The next steps in cervical screening. Womens Health (Lond Engl). 2015 Mar;11(2):201-12. |
| Thulaseedharan J.V., Malila N., Esmy P.O., Muwonge R., Hakama M., Sankaranarayanan R. Risk of invasive cancer among women visually screened and colposcopy triaged by trained nurses in rural South India. Int J Gynaecol Obstet. 2015;129(2):104-8. |
| Thulaseedharan J.V., Malila N., Swaminathan R., Esmy P.O., Cherian M., Hakama M., Muwonge R., Sankaranarayanan R. Effect of Screening on Variation in Cervical Cancer Survival by Socioeconomic Determinants - a Study from Rural South India. Asian Pac J Cancer Prev. 2015;16(13):5237-42. |
| Thulaseedharan J.V., Malila N., Swaminathan R., Esmy P.O., Hakama M., Muwonge R., Sankaranarayanan R. Survival of Patients With Cervical Cancer in Rural India. J Clin Gynecol Obstet. 2015;4(4):290-296. |
| Dolman L., Sauvaget C., Muwonge R., Sankaranarayanan R.. Meta-analysis of the efficacy of cold coagulation as a treatment method for cervical intraepithelial neoplasia: a systematic review. BJOG. 2014;121(8):929-42. |
| Joshi S., Babu J.M., Jayalakshmi D., Kulkarni V., Divate U., Muwonge R., Gheit T., Tommasino M., Sankaranarayanan R., Pillai M.R. Human papillomavirus infection among human immunodeficiency virus-infected women in Maharashtra, India. Vaccine. 2014;32(9):1079-85. |
| Muwonge R., Wesley R.S., Nene B.M., Shastri S.S., Jayant K., Malvi S.G., Thara S., Sankaranarayanan R. Evaluation of cytology and visual triage of human papillomavirus-positive women in cervical cancer prevention in India.Int J Cancer. 2014;134(12):2902-9. |
| Pathy S., Muwonge R., Chander S., Dadhwal V., Pandjatcharam J. Predictors of tumor response in carcinoma of uterine cervix: data from tertiary cancer centre in India. Predictors of tumor response in carcinoma of uterine cervix: data from tertiary cancer centre in India. Bull Cancer. 2014;101(2):E13-E8. |
| Sankaranarayanan R. Cancer prevention and care in India: an unfinished agenda. Lancet Oncol. 2014;15(6):554-5. |
| Sankaranarayanan R. Magnivisualizer in the early detection of cervical neoplasia. J Gynecol Oncol. 2014;25(4):263-4. |
| Sankaranarayanan R. Screening for Cancer in Low- and Middle-Income Countries. Ann Glob Health. 2014;80(5):412-7. |
| Sankaranarayanan R., Esmy P.O., Rajkumar R., Muwonge R., Swaminathan R. Cervical cancer mortality in India - Authors' reply. Lancet. 2014;383(9931):1804-5. |
| Sankaranarayanan R., Nene B.M., Shastri S., Esmy P.E., Rajkumar R., Muwonge R., Swaminathan R., Malvi S.G., Kane S., Desai S., Kelkar R., Hingmire S., Jayant K. Response to article titled "US-funded measurements of cervical cancer death rates in India: scientific and ethical concerns" by Eric J Suba. Indian J Med Ethics. 2014;11(3):175-8. |
| Sankaranarayanan R., Ramadas K., Qiao Y.L. Managing the changing burden of cancer in Asia. BMC Med. 2014;12:3. |
| Tchounga B.K., Jaquet A., Coffie P.A., Horo A., Sauvaget C., Adoubi I., Guie P., Dabis F., Sasco A.J., Ekouevi D.K. Cervical cancer prevention in reproductive health services: knowledge, attitudes and practices of midwives in Cote d'Ivoire, West Africa. BMC Health Serv Res. 2014;14:165. |
| Wild C.P., Bray F., Forman D., Franceschi S., Sankaranarayanan R., Straif K. Cancer in the 25×25 non-communicable disease targets.Lancet. 2014;384(9953):1502-3. |
| Bosch F.X., Broker T.R., Forman D., Moscicki A.B., Gillison M.L., Doorbar J., Stern P.L., Stanley M., Arbyn M., Poljak M., Cuzick J., Castle P.E., Schiller J.T., Markowitz L.E., Fisher W.A., Canfell K., Denny L.A., Franco E.L., Steben M., Kane M.A., Schiffman M., Meijer C.J., Sankaranarayanan R., Castellsague X., Kim J.J., Brotons M., Alemany L., Albero G., Diaz M., de Sanjose S.; Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013;31 Suppl 8:I1-I31. |
| Denny L.A., Sankaranarayanan R., De Vuyst H., Kim J.J., Adefuye P.O., Alemany L., Adewole I.F., Awolude O.A., Parham G., de Sanjose S., Bosch F.X. Recommendations for cervical cancer prevention in sub-saharan Africa. Vaccine. 2013;31 Suppl 5:F73-F4. |
| Joshi S., Sankaranarayanan R., Muwonge R., Kulkarni V., Somanathan T., Divate U. Screening of cervical neoplasia in HIV-infected women in India. AIDS. 2013;27(4):607-15. |
| Paolino M., Sankaranarayanan R., Arrossi S. Social determinants of dropout from diagnosis and treatment by women with abnormal Pap smears in Buenos Aires, Argentina. Rev Panam Salud Publica. 2013;34(6):437-45. |
| Sankaranarayanan R., Anorlu R., Sangwa-Lugoma G., Denny L.A. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-saharan Africa. Vaccine. 2013;31 Suppl 5:F47-F52. |
| Sauvaget C., Muwonge R., Sankaranarayanan R. Meta-analysis of the effectiveness of cryotherapy in the treatment of cervical intraepithelial neoplasia. Int J Gynaecol Obstet. 2013;120(3):218-23. |
| Thulaseedharan J.V., Malila N., Hakama M., Esmy P.O., Cherian M., Swaminathan R., Muwonge R., Sankaranarayanan R. Effect of screening on the risk estimates of socio demographic factors on cervical cancer - a large cohort study from rural India. Asian Pac J Cancer Prev. 2013;14(1):589-94. |
| Wesley R.S., Muwonge R., Sauvaget C., Thara S., Sankaranarayanan R. Effectiveness of cryotherapy for histologically confirmed cervical intraepithelial neoplasia grades 1 and 2 in an Indian setting. Int J Gynaecol Obstet. 2013;123(1):16-20. |
| Arbyn M., Ronco G., Anttila A., Meijer C.J., Poljak M., Ogilvie G., Koliopoulos G., Naucler P., Sankaranarayanan R., Peto J. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012;30 Suppl 5:F88-F99. |
| Arrossi S., Maceira V., Paolino M., Sankaranarayanan R. Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: a population-based survey. Vaccine. 2012;30(14):2467-74. |
| Cuzick J., Bergeron C., von Knebel Doeberitz M., Gravitt P., Jeronimo J., Lorincz A.T., J L M Meijer C., Sankaranarayanan R., J F Snijders P., Szarewski A. New technologies and procedures for cervical cancer screening. Vaccine. 2012;30 Suppl 5:F107-F16. |
| Deodhar K., Gheit T., Vaccarella S., Romao C.C., Tenet V., Nene B.M., Jayant K., Kelkar R., Malvi S.G., Sylla B.S., Franceschi S., Jeronimo J., Shastri S., Sankaranarayanan R., Tommasino M. Prevalence of human papillomavirus types in cervical lesions from women in rural Western India. J Med Virol. 2012;84(7):1054-60. |
| Deodhar K., Sankaranarayanan R., Jayant K., Jeronimo J., Thorat R., Hingmire S., Muwonge R., Chiwate A., Deshpande R., Ajit D., Kelkar R., Rekhi B., Ruben I., Malvi S.G., Chinoy R., Jambhekar N., Nene B.M. Accuracy of concurrent visual and cytology screening in detecting cervical cancer precursors in rural India. Int J Cancer. 2012;131(6):E954-62. |
| Forman D., Franceschi S., Sankaranarayanan R., Bray F., Ferlay J., Dikshit R., Jha P., Wild C.P. Do cervical cancer data justify human papillomavirus vaccination in India? Epidemiological data sources and comprehensiveness. J R Soc Med. 2012;105(9):365-6. |
| Khuhaprema T., Attasara P., Srivatanakul P., Sangrajrang S., Muwonge R., Sauvaget C., Sankaranarayanan R. Organization and evolution of organized cervical cytology screening in Thailand. Int J Gynaecol Obstet. 2012;118(2):107-11. |
| Sankaranarayanan R. 'See-and-treat' works for cervical cancer prevention: What about controlling the high burden in India? Indian J Med Res. 2012;135(5):576-9. |
| Sankaranarayanan R., Nessa A., Esmy P.O., Dangou J.M. Visual inspection methods for cervical cancer prevention. Best Pract Res Clin Obstet Gynaecol. 2012;26(2):221-32. |
| Santesso N., Schunemann H., Blumenthal P., De Vuyst H., Gage J., Garcia F., Jeronimo J., Lu R., Luciani S., Quek S.C., Awad T., Broutet N.; World health Organization Steering Committee for Recommendations on Use of Cryotherapy for Cervical Cancer Prevention. World Health Organization Guidelines: Use of cryotherapy for cervical intraepithelial neoplasia. Int J Gynaecol Obstet. 2012;118(2):97-102. |
| Saxena U., Sauvaget C., Sankaranarayanan R. Evidence-based Screening, Early Diagnosis and Treatment Strategy of Cervical Cancer for National Policy in Low- resource countries: Example of India. Asian Pac J Cancer Prev. 2012;13(4):1699-703. |
| Stock E.M., Stamey J.D., Sankaranarayanan R., Young D.M., Muwonge R., Arbyn M. Estimation of disease prevalence, true positive rate, and false positive rate of two screening tests when disease verification is applied on only screen-positives: A hierarchical model using multi-center data. Cancer Epidemiol. 2012;36(2):153-60. |
| Teguete I., Muwonge R., Traore C.B., Dolo A., Bayo S., Sankaranarayanan R. Can visual cervical screening be sustained in routine health services? Experience from Mali, Africa. BJOG. 2012;119(2):220-6. |
| Thulaseedharan J.V., Malila N., Hakama M., Esmy P.O., Cheriyan M., Swaminathan R., Muwonge R., Sankaranarayanan R. Socio demographic and reproductive risk factors for cervical cancer - a large prospective cohort study from rural India. Asian Pac J Cancer Prev. 2012;13(6):2991-5. |
| Namujju P.B., Waterboer T., Banura C., Muwonge R., Mbidde E.K., Byaruhanga R., Muwanga M., Surcel H.M., Pawlita M., Lehtinen M. Risk of seropositivity to multiple oncogenic human papillomavirus types among human immunodeficiency virus-positive and -negative Ugandan women. J Gen Virol. 2011;92(Pt 12):2776-83. |
| Sankaranarayanan R., Sauvaget C., Ramadas K., Ngoma T., Teguete I., Muwonge R., Naud P., Nessa A., Kuhaprema T., Qiao Y. Clinical trials of cancer screening in the developing world and their impact on cancer healthcare. Ann Oncol. 2011;22 Suppl 7:vii20-vii8. |
| Sauvaget C., Fayette J.M., Muwonge R., Wesley R., Sankaranarayanan R. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet. 2011;113(1):14-24. |
| Sauvaget C., Nene B.M., Jayant K., Kelkar R., Malvi S.G., Shastri S.S., Sankaranarayanan R. Prevalence and determinants of high-risk human papillomavirus infection in middle-aged Indian women. Sex Transm Dis. 2011 Oct;38(10):902-6. |
| Arrossi S., Paolino M., Sankaranarayanan R. Challenges faced by cervical cancer prevention programs in developing countries: a situational analysis of program organization in Argentina. Rev Panam Salud Publica. 2010;28(4):249-57. |
| Missaoui N., Hmissa S., Sankaranarayanan R., Deodhar K., Nene B., Budukh A., Malvi S., Chinoy R., Kelkar R., Kane S., Chauhan M., Kothai A., Kahate S., Fontaniere B., Frappart L. p16INK4A overexpression is a useful marker for uterine cervix lesions. In French. Ann Biol Clin (Paris). 2010;68(4):409-14. |
| Muwonge R., Manuel Mda G., Filipe A.P., Dumas J.B., Frank M.R., Sankaranarayanan R. Visual screening for early detection of cervical neoplasia in Angola. Int J Gynaecol Obstet. 2010;111(1):68-72. |
| Nessa A., Hussain M.A., Rahman J.N., Rashid M.H., Muwonge R., Sankaranarayanan R. Screening for cervical neoplasia in Bangladesh using visual inspection with acetic acid. Int J Gynaecol Obstet. 2010;111(2):115-8. |
| Pimple S., Muwonge R., Amin G., Goswami S., Sankaranarayanan R., Shastri S.S. Cytology versus HPV testing for the detection of high-grade cervical lesions in women found positive on visual inspection in Mumbai, India. Int J Gynaecol Obstet. 2010;108(3):236-9. |
| Anttila A., von Karsa L., Aasmaa A., Fender M., Patnick J., Rebolj M., Nicula F., Vass L., Valerianova Z., Voti L., Sauvaget C., Ronco G. Cervical cancer screening policies and coverage in Europe. Eur J Cancer. 2009;45(15):2649-58. |
| Bhatla N., Gulati A., Mathur S.R., Rani S., Anand K., Muwonge R., Sankaranarayanan R. Evaluation of cervical screening in rural North India. Int J Gynecol Obstet. 2009;105(2):145-9. |
| Gheit T., Vaccarella S., Schmitt M., Pawlita M., Franceschi S., Sankaranarayanan R., Sylla B.S., Tommasino M., Gangane N. Prevalence of human papillomavirus types in cervical and oral cancers in central India. Vaccine. 2009;27(5):636-9. |
| Kerner J.F., Cazap E., Yach D., Pierotti M.A., Daidone M.G., de Blasio P., Geary P., Schacter B., Sant M., Habbema J.D., Sankaranarayanan R., Sutcliffe C., Sutcliffe S. Comprehensive cancer control-research & development: knowing what we do and doing what we know. Tumori. 2009;95(5):610-22. |
| Muwonge R., Mbalawa C.G., Keita N., Dolo A., Nouhou H., Nacoulma M., Malanda J.N., Koulibaly M., Bayo S., Sankaranarayanan R.; IARC Multicentre Study Group on Cervical Cancer Early Detection. Performance of colposcopy in five sub-Saharan African countries. BJOG. 2009;116(6):829-37. |
| Sankaranarayanan R. HPV vaccination: the promise & problems. Indian J Med Res. 2009;130(3):322-6. |
| Sankaranarayanan R., Keshkar V., Kothari A., Kane S., Fayette J.M., Shastri S. Effectiveness and safety of loop electrosurgical excision procedure for cervical neoplasia in rural India. Int J Gynecol Obstet. 2009;104(2):95-9. |
| Sankaranarayanan R., Nene B.M., Shastri S.S., Jayant K., Muwonge R., Budukh A.M., Hingmire S., Malvi S.G., Thorat R., Kothari A., Chinoy R., Kelkar R., Kane S., Desai S., Keskar V.R., Rajeshwarkar R., Panse N., Dinshaw K.A. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360(14):1385-94. |
| Sherris J., Wittet S., Kleine A., Sellors J., Luciani S., Sankaranarayanan R., Barone M.A. Evidence-based, alternative cervical cancer screening approaches in low-resource settings. Int Perspect Sex Reprod Health. 2009;35(3):147-54. |
| Arbyn M., Sankaranarayanan R., Muwonge R., Keita N., Dolo A., Mbalawa C.G., Nouhou H., Sakande B., Wesley R., Somanathan T., Sharma A., Shastri S., Basu P. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer. 2008;123(1):153-60. |
| Arrossi S., Ramos S., Paulino M., Sankaranarayanan R. Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina. Reprod Health Matters. 2008;16(32):50-8. |
| Cuzick J., Arbyn M., Sankaranarayanan R., Tsu V., Ronco G., Mayrand M.H., Dillner J., Meijer C.J. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 2008;26(Suppl 10):K29-K41. |
| Garland S.M., Cuzick J., Domingo E.J., Goldie S.J., Kim Y.T., Konno R., Parkin D.M., Qiao Y.L., Sankaranarayanan R., Stern P.L., Tay S.K., Bosch F.X. Recommendations for cervical cancer prevention in Asia Pacific. Vaccine. 2008;26(Suppl 12):M89-M98. |
| Nene B.M., Hiremath P.S., Kane S., Fayette J.M., Shastri S.S., Sankaranarayanan R. Effectiveness, safety, and acceptability of cryotherapy by midwives for cervical intraepithelial neoplasia in Maharashtra, India. Int J Gynaecol Obstet. 2008;103(3):232-6. |
| Ramadas K., Arrossi S., Thara S., Thomas G., Jissa V., Fayette J.M., Mathew B., Sankaranarayanan R. Which socio-demographic factors are associated with participation in oral cancer screening in the developing world? Results from a population-based screening project in India. Cancer Detect Prev. 2008;32(2):109-15. |
| Rema P., Suchetha S., Thara S., Fayette J.M., Wesley R., Sankaranarayanan R. Effectiveness and safety of loop electrosurgical excision procedure in a low-resource setting. Int J Gynaecol Obstet. 2008;103(2):105-10. |
| Sankaranarayanan R. Commentary: Cancer incidence among Asian Indians in India and abroad. Int J Epidemiol. 2008;37(1):160-1. |
| Sankaranarayanan R., Bhatla N., Gravitt P.E., Basu P., Esmy P.O., Ashrafunnessa K.S., Ariyaratne Y., Shah A., Nene B.M. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal. Vaccine. 2008;26(Suppl 12):M43-M52. |
| Sankaranarayanan R., Thara S., Esmy P.O., Basu P. Cervical cancer: screening and therapeutic perspectives. Med Princ Pract. 2008;17(5):351-64. |
| Varghese C., Nongkynrih B., Srinivasan R., Sankaranarayanan R., Basu P., Rajwanshi A. Cervical cancer screening programme for low-resource settings: a pragmatic approach. Regional Health Forum. 2008 (Volume 12, number 2): 5-15. |
| Arrossi S., Matos E., Zengarini N., Roth B., Sankaranarayanan R., Parkin M. The socio-economic impact of cervical cancer on patients and their families in Argentina, and its influence on radiotherapy compliance. Results from a cross-sectional study. Gynecol Oncol. 2007;105(2):335-40. |
| Deerasamee S., Srivatanakul P., Sriplung H., Nilvachararung S., Tansuwan U., Pitakpraiwan P., Kaewkungwal J., Singhasivanon P., Nimnakorn P., Sankaranarayanan R. Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand. Asian Pac J Cancer Prev. 2007 Oct-Dec;8(4):547-56. |
| Muwonge R., Walter S.D., Wesley R.S., Basu P., Shastri S.S., Thara S., Mbalawa C.G., Sankaranarayanan R.; The IARC Multicentre Study Group on Cervical Cancer Early Detection. Assessing the gain in diagnostic performance when two visual inspection methods are combined for cervical cancer prevention. J Med Screen. 2007;14(3):144-50. |
| Nene B., Jayant K., Arrossi S., Shastri S., Budukh A., Hingsmire S., Muwonge R., Malvi S., Dinshaw K., Sankaranarayanan R. Determinants of women’s participation in cervical cancer screening trial, Maharashtra, India. Bull World Health Organ. 2007;85(4):264-72. |
| Sankaranarayanan R., Esmy P.O., Rajkumar R., Muwonge R., Swaminathan R., Shanthakumari S., Fayette J.M., Cherian J. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet. 2007;370(9585):398-406. |
| Sankaranarayanan R., Rajkumar R., Esmy P.O., Fayette J.M., Shanthakumary S., Frappart L., Thara S., Cherian J. Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India. Br J Cancer. 2007;96(5):738-43. |
| Sherris J., Wright T.C., Denny L., Sankaranarayanan R., Pollack A.E., Sanghvi H., Sellors J.W. Alliance for cervical cancer prevention: setting the record straight. Am J Public Health. 2007;97(2):200-1. |
| Wright T.C., Blumenthal P., Bradley J., Denny L., Esmy P.O., Jayant K., Nene B.M., Pollack A.E., Rajkumar R., Sankaranarayanan R., Sellors J.W., Shastri S.S., Sherris J., Tsu V. Cervical cancer prevention for all the world's women: New approaches offer opportunities and promise. Diagn Cytopathol. 2007;35(12):845-8. |
| Arbyn M., Tulunay G., Ozgul N., Yalvac S., Verguts J., Poppe W., Sankaranarayanan R. European Union support for a Turkish reproductive health project to assess alternative cervical cancer screening methods in Sanliurfa (rural south-east Turkey). Eur J Cancer Prev. 2006;15(6):552-3. |
| Basu P., Sarkar S., Mukherjee S., Ghosal M., Mittal S., Biswas S., Mandal R., Sankaranarayanan R. Women's perceptions and social barriers determine compliance to cervical screening: Results from a population based study in India. Cancer Detect Prev. 2006;30(4):369-74. |
| Bradley J., Coffey P., Arrossi S., Agurto I., Bingham A., Dzuba I., Kleine A., Lewis R., White S. Women's perspectives on cervical screening and treatment in developing countries: experiences with new technologies and service delivery strategies. Women & Health. 2006;43(3):103-21. |
| Denny L., Quinn M., Sankaranarayanan R. Chapter 8: Screening for cervical cancer in developing countries. Vaccine. 2006;24(Suppl 3):S71-S7. |
| Denny L., Sankaranarayanan R. Secondary prevention of cervical cancer. Int J Gynaecol Obstet. 2006;94(Suppl 1):S65-S70. |
| Sankaranarayanan R. Overview of cervical cancer in the developing world. Int J Gynaecol Obstet. 2006;95(Suppl 1):S205-S10. |
| Sankaranarayanan R. Preventing cervical cancer in low-resource settings. Ind J Gynaecol Oncol. 2006;6(Suppl 1):13-7. |
| Sankaranarayanan R., Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006;20(2):207-25. |
| Sankaranarayanan R., Dinshaw K., Nene B.M., Ramadas K., Esmy P.O., Jayant K., Somanathan T., Shastri S. Cervical and oral cancer screening in India. J Med Screen. 2006;13(Suppl 1):S35-S8. |
| Agurto I., Arrossi S., White S., Coffey P., Dzuba I., Bingham A., Bradley J., Lewis R. Involving the community in cervical cancer prevention programs. Int J Gynaecol Obstet. 2005;89(Suppl 2):S38-S45. |
| Blumenthal P., Lauterbach J., Sellors J., Sankaranarayanan R. Training for cervical cancer prevention programs in low-resource settings: focus on visual inspection with acetic acid and cryotherapy. Int J Gynaecol Obstet. 2005;89(Suppl 2):S30-S7. |
| Bradley J., Barone M., Mahe C., Lewis R., Luciani S. Delivering cervical cancer prevention services in low-resource settings. Int J Gynaecol Obstet. 2005;89(Suppl 2):S21-S9. |
| Franceschi S., Mahe C. Human papillomavirus testing in cervical cancer screening. Br J Cancer. 2005 92(9):1591-2. |
| Franceschi S., Rajkumar R., Snijders P.J., Arslan A., Mahe C., Plummer M., Sankaranarayanan R., Cherian J., Meijer C.J., Weiderpass E. Papillomavirus infection in rural women in southern India. Br J Cancer. 2005;92(3):601-6. |
| Goldie S.J., Gaffikin L., Goldhaber-Fiebert J.D., Gordillo-Tobar A., Levin C., Mahe C., Wright T.C., for the Alliance for Cervical Cancer Prevention Cost Working Group. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005;353(20):2158-68. |
| Legood R., Gray A.M., Mahe C., Wolstenholme J., Jayant K., Nene B.M., Shastri S., Malvi S.G., Muwonge R., Budukh A.M., Sankaranarayanan R. Screening for cervical cancer in India: How much will it cost? A trial based analysis of the cost per case detected. Int J Cancer. 2005;117(6):981-7. |
| Mahe C., Gaffikin L. Screening test accuracy studies: how valid are our conclusions? Application to visual inspection methods for cervical screening. Cancer Causes Control. 2005;16(6):657-66. |
| Sankaranarayanan R. Screening for cervical and oral cancers in India is feasible and effective. National Med J India. 2005;18(6):281-4. |
| Sankaranarayanan R., Gaffikin L., Jacob M., Sellors J., Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet. 2005;89(Supp 2):S4-S12. |
| Sankaranarayanan R., Nene B.M., Dinshaw K.A., Mahe C., Jayant K., Shastri S.S., Malvi S.G., Chinoy R., Kelkar R., Budukh A.M., Keskar V., Rajeshwarker R., Muwonge R., Kane S., Parkin D.M., Chauhan M.K., Desai S., Fontaniere B., Frappart L., Kothari A., Lucas E., Panse N.; Osmanabad District Cervical Screening Study Group. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer. 2005;116(4):617-23. |
| Shastri S.S., Dinshaw K., Amin G., Goswami S., Patil S., Chinoy R., Kane S., Kelkar R., Muwonge R., Mahe C., Ajit D., Sankaranarayanan R. Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ. 2005;83(3):186-94. |
| Sherris J., Agurto I., Arrossi S., Dzuba I., Gaffikin L., Herdman C., Limpaphayom K., Luciani S. Advocating for cervical cancer prevention. Int J Gynaecol Obstet. 2005;89(Suppl 2):S46-S54. |
| Monsonego J., Bosch F.X., Coursaget P., Cox J.T., Franco E., Frazer I., Sankaranarayanan R., Schiller J., Singer A., Wright T.C. Jr, Kinney W., Meijer C.J., Linder J., McGoogan E., Meijer C. Cervical cancer control, priorities and new directions. Int J Cancer. 2004;108(3):329-33. |
| Sankaranarayanan R., Basu P., Wesley R.S., Mahe C., Keita N., Gombe Mbalawa C.C., Sharma R., Dolo A., Shastri S.S., Nacoulma M., Nayama M., Thara S., Lucas E., Muwonge R., Parkin D.M.; IARC Multicentre Study Group on Cervical Cancer Early Detection. Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa. Int J Cancer. 2004;110(6):907-13. |
| Sankaranarayanan R., Chatterji R., Shastri S.S., Wesley R.S., Basu P., Mahe C., Muwonge R., Seigneurin D., Thara S., Roy C., Kelkar R., Chinoy R., Dinshaw K., Mandal R., Amin G., Goswami S., Pal S., Patil S., Dhakad N., Frappart L., Fontaniere B. for the IARC multicentre study group on cervical cancer prevention in India. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer. 2004;112(2):341-7. |
| Sankaranarayanan R., Rajkumar R., Theresa R., Esmy P.O., Mahe C., Bagyalakshmi K.R., Thara S., Frappart L., Lucas E., Muwonge R., Shanthakumari S., Jeevan D., Subbarao T.M., Parkin D.M., Cherian J. Initial results from a randomized trial of cervical visual screening in rural south India. Int J Cancer. 2004 Apr 10;109(3):461-7. |
| Sankaranarayanan R., Shastri S.S., Basu P., Mahe C., Mandal R., Amin G., Roy C., Muwonge R., Goswami S., Das P., Chinoy R., Frappart L., Patil S., Choudhury D., Mukherjee T., Dinshaw K. The role of low-level magnification in visual inspection with acetic acid for the early detection of cervical neoplasia. Cancer Detect Prev. 2004;28(5):345-51. |
| Sankaranarayanan R., Thara S., Sharma A., Roy C., Shastri S., Mahe C., Muwonge R., Fontaniere B. Multicentre Study Group on Cervical Cancer Early Detection in India. Accuracy of conventional cytology: Results from a multicentre screening study in India. J Med Screen. 2004;11(2):77-84. |
| Arrossi S., Sankaranarayanan R., Parkin D.M. Incidence and mortality of cervical cancer in Latin America. Salud Publica Mex. 2003;45 Suppl 3:S306-14. |
| Basu P., Sankaranarayanan R., Mandal R., Roy C., Das P., Choudhury D., Bhattacharya D., Chatterjee R., Dutta K., Barik S., Tsu V., Chakrabarti R.N., Siddiqi M.; Calcutta Cervical Cancer Early Detection Group. Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India. Int J Gynecol Cancer. 2003;13(5):626-32. |
| Sankaranarayanan R., Nene B.M., Dinshaw K., Rajkumar R., Shastri S.S., Wesley R., Basu P., Sharma R., Thara S., Budukh A., Parkin D.M. Early detection of cervical cancer with visual inspection methods: A summary of completed and on-going studies in India. Salud Publica Mex 2003;45 Suppl 3:S399-407. |
| Sankaranarayanan R., Rajkumar R., Arrossi S., Theresa R., Esmy P.O., Mahe C., Muwonge R., Parkin D.M., Cherian J. Determinants of participation of women in a cervical cancer visual screening trial in rural south India. Cancer Detect Prev. 2003;27(6):457-65. |
| Sankaranarayanan R., Wesley R., Thara S., Dhakad N, Chandralekha B, Sebastian P, Chithrathara K, Parkin DM, Nair MK. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening for Kerala, India. Int J Cancer. 2003; 106(3):404-8. |
| Wang H., Chia K.S., Du W.B., Lee J., Sankaranarayanan R., Sankila R., Sng I., Seow A., Lee H.P. Population-based survival for cervical cancer in Singapore, 1968-1992. Am J Obstet Gynecol. 2003;188(2):324-9. |
| Sankaranarayanan R. Royal Society of Tropical Medicine and Hygiene meeting at Manson House, London 17 January 2002. Cervical cancer in developing countries. Trans R Soc Trop Med Hyg. 2002 Nov-Dec;96(6):580-5. |
| Sellors J.W., Jeronimo J., Sankaranarayanan R., Wright T.C., Howard M., Blumenthal P.D. Assessment of the cervix after acetic acid wash: inter-rater agreement using photographs.
Obstet Gynecol. 2002 Apr;99(4):635-40. |
| Richart R.M., Robles S., Sankaranarayanan R., Wright T.C. Cervical cancer screening strategies for developing countries. Symposium. Contemporary OB/GYN. 2001;46(1):71-2,74,79. |
| Sankaranarayanan R., Budukh A.M., Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79(10):954-62. Epub 2001 Nov 01. Review. |
| Miller A.B., Nazeer S., Fonn S., Brandup-Lukanow A., Rehman R., Cronje H., Sankaranarayanan R., Koroltchouk V., Syrjanen K., Singer A., Onsrud M. Report on consensus conference on cervical cancer screening and management. Int J Cancer. 2000;86(3):440-7. |
| Parkin D.M., Sankaranarayanan R. Prevention of cervical cancer in developing countries. Thai J Obst Gynaecol 1999, 11, 3-20. |
| Sankaranarayanan R., Syamalakumary B., Wesley R., Amma N.S., Parkin D.M., Nair M.K. Visual inspection with acetic acid in the early detection of cervical cancer and precursors. Int J Cancer. 1999 Jan 5;80(1):161-3. |
| Sankaranarayanan R., Wesley R., Somanathan T., Dhakad N., Shyamalakumary B., Amma N.S., Parkin D.M., Nair M.K. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer. 1998 Nov 15;83(10):2150-6. |
| Yeole B.B., Sankaranarayanan R., Jussawalla D.J. Long-term survival from uterine cervical cancer in Mumbai (Bombay), India. Int J Cancer. 1998 Oct 29;78(3):394-5. |
| Wesley R., Sankaranarayanan R., Mathew B., Chandralekha B., Beegum A., Amma N.S., Nair M.K. Evaluation of visual inspection as a screening test for cervical cancer. Br J Cancer. 1997;75(3):436-40. |
| Nene B.M., Deshpande S., Jayant K., Budukh A.M., Dale P.S., Deshpande D.A., Chiwate A.S., Malvi S.G., Deokar S., Parkin D.M., Sankaranarayanan R. Early detection of cervical cancer by visual inspection: a population-based study in rural India. Int J Cancer. 1996 Dec 11;68(6):770-3. |
| Sankaranarayanan R., Nair M.K., Jayaprakash P.G., Stanley G., Varghese C., Ramadas V., Padmakumary G., Padmanabhan T.K. Cervical cancer in Kerala: a hospital registry-based study on survival and prognostic factors. Br J Cancer. 1995 Oct;72(4):1039-42. |
Book chapters:
| 2014 Sankaranarayanan R. Treatment of precancerous cervical lesions. In: Grigsby P.W., editor. Advances in cervical cancer management. London, UK: Future Medicine Ltd; 2014. p. 101-21. |
| 2013 Sankaranarayanan R., Ferlay J. Chapter 1. Burden of breast and gynecological cancers in low-resource countries. In: Shetty M.K., (ed). Breast and gynecological cancers: an integrated approach for screening and early diagnosis in developing countries. New York: Springer. 2013, pp.1-17. |
| 2013 Sankaranarayanan R., Ramadas K., Grosse Frie K., Qiao Y.L. Chapter 12. Challenges for breast and gynecological cancer control by early detection in less developed countries. In: Shetty M.K., (ed). Breast and gynecological cancers: an integrated approach for screening and early diagnosis in developing countries. New York: Springer. 2013, pp.215-227. |
| 2011 Sankaranarayanan R., Esmy P.O., Thara S., Naud P., Keita N., Ngoma T. Chapter 1. Cervical Cancer Screening in the Developing World. In: Rajaram S., Chitrathara K., Maheswari A. (eds). Cervical Cancer Contemporary Management. New Delhi: Jaypee Brothers Medical Publishers (P) LTD. 2011, pp. 3-14. |
| 2011 Sankaranarayanan R., Ferlay J. Global Burden of Gynaecological Cancer. In: Ayhan A., Reed N., Gultekin M., Dursun P. (eds). Textbook of gynaecological oncology. Ankara: Gunes Publishing. 2011, pp. 219-227. |
| 2011 Sankaranarayanan R., Jivarajani P., Joshi S. Chapter 9. HPV Vaccination in Primary Prevention of Cervical Cancer. In: Rajaram S., Chitrathara K., Maheswari A. (eds). Cervical Cancer Contemporary Management. New Delhi: Jaypee Brothers Medical Publishers (P) LTD. 2011, pp. 66-73. |
| 2010 Sankaranarayanan R., Thara S., Ngoma T., Naud P., Keita N. Cervical Cancer Screening in the Developing World. In: Finkel, M. (eds). Public Health in the 21st Century, Santa Barbara, Ca: Prager Publishing. 2011, 231-244. |
| 2009 Sankaranarayanan R., Ferlay J. Worldwide burden of gynaecological cancer. In: Preedy V.R. and Watson R.R. (eds). Handbook of Disease Burdens and Quality of Life Measures. Springer, pp. 804-823. |
| 2009 Sankaranarayanan R., Ferlay J.. Global Burden of Gynaecological Cancer. In: Ayhan A., Gultekin M., Dursun P. (eds). Textbook of Gynaecological Oncology. Gunes Publishing 2009, pp. 106-114. |
| 2008 Sankaranarayanan R, Sauvaget C. HPV vaccination in the developing world. In: Stern PL, Kitchener HC, editors. Vaccines for the Prevention of Cervical Cancer. 2008. p. 103-13. |
| 2006 Arrossi S., Sankaranarayanan R., Parkin D.M. Incidencia y Mortalidad del cancer cervicouterino en America Latina. En: Alonso P., Lazcano-Ponce E., Hernandez M. (Editores). Cancer cervicouterino. Diagnostico, prevencion y control. Segunda Edicion. Mexico, Editorial Medica Panamericana; p 179-199; 2006. |
| 2006 Sankaranarayanan R., Thara S., Ngoma T. Visual screening for cervical neoplasia. In: Jordan J., Singer A., Jones H., Shafi M. (eds). The Cervix. Blackwell Publishing, London, Chapter 29B; 2006, pp. 434-441. |
| 1997 Sankaranarayanan R., Pisani P. Prevention measures in the third world: are they practical? In: Franco E., Monsonego J., eds, New developments in cervical cancer screening and prevention. Blackwell Science, Oxford, 1997, pp. 70-83. |
| 1997 Sankaranarayanan R., Shyamalakumari B., Wesley R., Thara S., Chandralekha B., Sreedevi Amma N., Nair M.K. Visual inspection as a screening test for cervical cancer control in developing countries. In: Franco E., Monsonego J., eds, New developments in cervical cancer screening and prevention. Blackwell Science, Oxford, 1997, pp. 411-421. |
| 1993 Sankaranarayanan R. Risk factors for carcinoma cervix. In: Bhattathiri VN, Rajan B, Blake P, Krishnan Nair M, eds, Cervical Cancer in Developing Countries, Proceedings of the XI International Working Party Meeting. Regional Cancer Centre, Trivandrum, 1993, pp. 3-6. |
Letters:
| 1988 Sankaranarayanan R. Risk factors in the aetiology of cancer of the uterine cervix leading to differential rates among Hindu and Muslim women in India. Br J Cancer. 1988 Apr;57(4):442. |
Books:
| 2003 Sankaranarayanan R, Wesley RS. A Practical Manual on Visual Screening for Cervical Neoplasia. IARC Technical Publication No. 41. International Agency for Research on Cancer, Lyon, 2003 (published in English, French, Spanish and Turkish). |
| 2003 Sellors JW and Sankaranarayanan R. Colposcopy and treatment of cervical intraepithelial neoplasia: a beginners’ manual. IARC Non serial publication, Lyon 2003 (published in English, French, Spanish, Portuguese and Chinese). |
Electronic publications:
| 2006 Sankaranarayanan R, Lucas E. A training course in Visual Inspection with 5% Acetic Acid (VIA) - Digital learning series. IARC Screening Group, Lyon, 2006. |
| 2006 Sankaranarayanan R, Lucas E. A training course in cryotherapy - Digital learning series. IARC Screening Group, Lyon, 2006. |
| 2006 Sankaranarayanan R, Lucas E. A training course in Visual Inspection with Lugol's Iodine solution (VILI) - Digital learning series. IARC Screening Group, Lyon, 2006. |
| 2006 Zhang WH, Keskar V, Lucas E, Qiao YL, Sankaranarayanan R. A training course in Loop electrosurgical excision procedure (LEEP) - Digital learning series. IARC Screening Group, Lyon, 2006. |
| 2004 Frappart L., Fontaniere B., Lucas E., Sankaranarayanan R. Histopathology and Cytopathology of the Uterine Cervix – Digital atlas. Lyon: IARCPress; 2004. |